LAUSR

1894. Clinical and Economic Comparison of Ceftaroline Fosamil (CPT) and Daptomycin (DAP) for Methicillin-Resistant Staphylococcus aureus (MRSA) Bloodstream Infections (BSI) Evan J. Zasowski, PharmD, BCPS; Trang D. Trinh, PharmD; Kimberly Claeys, PharmD, BCPS; Abdalhamid M. Lagnf, MPH; Kenneth Klinker, PharmD; Sandy Estrada, PharmD, BCPS (AQ-ID); Susan L Davis, PharmD; Vanthida Huang, PharmD; Brian A. Potoski, PharmD; Donald Levine, MD; Keith S. Kaye, MD, MPH; Nicole Bonine, PhD, MPH; Patrick Gillard, PharmD, MS and Michael J. Rybak, PharmD, MPH, PhD; Anti-Infective Research Laboratory, Department of Pharmacy Practice, Wayne State University, Eugene Applebaum College of Pharmacy & Health Sciences, Detroit, Michigan, University of Maryland School of Pharmacy, Baltimore, MD, Pharmacy, University of Florida College of Pharmacy, Gainesville, Florida, Department of Pharmacy, Lee Memorial Health System, Fort Myers, Florida, Wayne State University College of Pharmacy, Detroit, Michigan, College of Pharmacy, Midwestern University, Glendale, Arizona, University of Pittsburgh, Pittsburgh, Pennsylvania, Wayne State University School of Medicine, Detroit, Michigan, University of Michigan Medical School, Ann Arbor, Michigan, Allergan, plc, Irvine, California